TrialPloS one2016

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial.

Zeinab Hamidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.